Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies
NCT04076943Phase 2Completed
- Sponsor
- FibroGen
- Start
- Aug 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roxadustat in Chemotherapy-induced anemia (CIA), sponsored by FibroGen. Started Aug 2019; status: completed.
02
Drugs
roxadustat
03
Conditions
Chemotherapy-induced anemia (CIA)
Beyond the preview
Go deeper on NCT04076943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04076943.